These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 8328733

  • 1. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Aug 15; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 3. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J.
    Am J Kidney Dis; 1993 Dec 15; 22(6):808-13. PubMed ID: 8250027
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine.
    Doucet C, Mooser V, Gonbert S, Raymond F, Chapman J, Jacobs C, Thillet J.
    J Am Soc Nephrol; 2000 Mar 15; 11(3):507-513. PubMed ID: 10703674
    [Abstract] [Full Text] [Related]

  • 5. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Schärer K.
    Pediatr Res; 1993 Dec 15; 34(6):772-6. PubMed ID: 8108191
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E.
    Kidney Int; 1999 Sep 15; 56(3):1049-57. PubMed ID: 10469373
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D, Barbagallo CM, Cascio AL, Cefalù AB, Cavera G, Caldarella R, Marino G, Travali S, Cutaia I, Maringhini S, Notarbartolo A, Averna M.
    Kidney Int; 1999 Jun 15; 55(6):2433-9. PubMed ID: 10354292
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL.
    Atherosclerosis; 1991 Jan 15; 86(1):69-83. PubMed ID: 1829609
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein(a) in nephrotic syndrome.
    Stenvinkel P, Berglund L, Heimbürger O, Pettersson E, Alvestrand A.
    Kidney Int; 1993 Nov 15; 44(5):1116-23. PubMed ID: 8264144
    [Abstract] [Full Text] [Related]

  • 13. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
    Nakahara C, Kobayashi K, Hamaguchi H, Kanemoto K, Kashiwagi R, Matsui A.
    Pediatr Nephrol; 1999 Oct 15; 13(8):657-61. PubMed ID: 10502122
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS.
    Thyroid; 2003 Apr 15; 13(4):365-9. PubMed ID: 12804105
    [Abstract] [Full Text] [Related]

  • 15. Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.
    Yang X, Wang H, Zhu Z, Deng A.
    J Tongji Med Univ; 1998 Apr 15; 18(4):236-8. PubMed ID: 10806854
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J, Simó JM, Vilella E, Camps J, Espinel E, Villabona C.
    Clin Chem; 1995 Jun 15; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb 15; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C, Böhler J, Eckardt HG, Wieland H, Schollmeyer P.
    Clin Nephrol; 1994 Mar 15; 41(3):138-43. PubMed ID: 8187355
    [Abstract] [Full Text] [Related]

  • 20. A study of the clinical significance of lipoprotein (a) in nephrotic syndrome.
    Takegoshi T, Kitoh C, Haba T, Hirai J, Wakasugi T, Saga T, Yamazaki Y, Mabuchi H.
    Jpn J Med; 1991 Mar 15; 30(1):21-5. PubMed ID: 1830908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.